The head of Ranbaxy Laboratories Ltd. says he's charging ahead with plans to expand sales in the crucial US market, despite extra oversight from American regulators over quality questions that have blocked imports of 31 of its medicines.
Ranbaxy, which almost exclusively makes generic pills, particularly
Ranbaxy, which almost exclusively makes generic pills, particularly
